Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition for preventing and treating mild and moderate infection of helicobacter pylori

A technology of Helicobacter pylori and composition, which is applied in the direction of effective ingredients, applications, and food science of hydroxyl compounds, and can solve problems such as large side effects, easy re-infection, drug resistance, human digestive function nervous system and skeletal muscle damage, etc.

Pending Publication Date: 2020-10-20
山东健为生物科技有限公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although these drugs have played an important role in the treatment of diseases caused by Helicobacter pylori infection, after being cured, because Helicobacter pylori is very easy to reinfect and has strong drug resistance, after reinfection, the second time is like using the first time. The same drug, due to the development of drug resistance, its efficacy gradually decreases
In addition, the side effects of therapeutic drugs are relatively large, and antibiotics also accidentally injure beneficial bacteria in the human body. In particular, the main drug bismuth can cause irreversible damage to human digestive function, urinary system, nervous system and skeletal muscles.
Therefore, the existing treatment methods and the means of treatment with the above-mentioned drugs are not perfect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition for preventing and treating mild and moderate infection of helicobacter pylori

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0022] The composition disclosed by the present invention for preventing and treating mild and moderate Helicobacter pylori infection comprises a carrier, vitamin E and ascorbyl palmitate, and the carrier is vegetable oil containing unsaturated fatty acids, wherein the vegetable oil is composed of soybean oil, At least one of hemp oil, linseed oil and palm oil. Ascorbyl palmitate is an esterified derivative of vitamin C. In addition, the composition also contains any combination of β-carotene, vitamin C and vitamin A. Since ascorbyl palmitate slowly decomposes vitamin C in the human body, about 50% of β-carotene is converted into vitamin A in the human body, that is, β-carotene, vitamin C and vitamin A are added as supplementary substances.

[0023] The above composition uses vegetable oil as a carrier, and the following substances are added: vitamin E 0.0005-0.145%, ascorbyl palmitate 0.001-0.02%, β-carotene 0.0003-0.0006%, vitamin A 0.00003-0.0017%, vitamin C 0.005-1.3 %. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a composition for preventing and treating mild and moderate infection of helicobacter pylori, relates to the technical field of medical treatment and food, and particularly belongs to the composition for preventing and treating the mild and moderate infection of the helicobacter pylori. The composition is characterized by comprising a carrier, vitamin E and ascorbyl palmitate, wherein the carrier is vegetable oil containing unsaturated fatty acid; and the ascorbyl palmitate is an esterified derivative of vitamin C. Corresponding components are added according to food safety regulations and limits, the helicobacter pylori can be killed, certain side effects on human bodies are avoided, the problem of increasingly serious drug resistance stubborn diseases in clinic atpresent is solved, and the composition can be taken as a drug for preventing and treating the mild and moderate helicobacter pylori infection for a long time.

Description

technical field [0001] The invention relates to the technical fields of medical treatment and food, in particular to a composition for preventing and treating mild and moderate Helicobacter pylori infection. Background technique [0002] Helicobacter pylori is ubiquitous in the stomach and duodenum or oral cavity of humans and animals (macaques, rats, pigs, dogs, etc.). Helicobacter pylori includes canine Helicobacter pylori, Gastric Helicobacter, Helicobacter nigeri, Helicobacter Laponi and Helicobacter salomoni, etc. It is a Gram-negative bacillus, helical, microaerophilic, and resistant to growth. The conditions are very demanding. In 1983, it was successfully isolated from the gastric mucosal biopsy tissue of chronic active gastritis for the first time. According to incomplete statistics, about 50-60% of people have Helicobacter pylori in their stomachs, and almost 90% of people in some countries have been infected with this bacterium. People are usually infected at a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/375A61K31/015A61K31/07A61K31/355A61K47/44A61P31/04A23L33/15A23L33/115A23L33/155A23L33/105
CPCA61K31/355A61K31/375A61K31/015A61K31/07A61K47/44A61P31/04A23L33/15A23L33/115A23L33/155A23L33/105A23V2002/00A61K2300/00A23V2200/32A23V2200/308A23V2200/30A23V2250/18A23V2250/211A23V2250/708A23V2250/702A23V2250/712
Inventor 王世国程维佳
Owner 山东健为生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products